Headline News about Axsome Thera
Axsome Therapeutics Targets Submission Of US Application For Fibromyalgia Candidate By 2022
June 15, 2021
Via Benzinga
Exposures
Product Safety
Axsome Therapeutics Stock Jumps As FDA Accepts AXS-05 Application In Major Depressive Disorder
April 26, 2021
Via Benzinga
Exposures
Product Safety
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|